Nutex Health Price to Book Ratio 2016-2025 | NUTX
Historical price to book ratio values for Nutex Health (NUTX) over the last 10 years. The current price to book ratio for Nutex Health as of June 26, 2025 is 2.43.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Nutex Health Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-06-26 | 118.46 | 2.38 | |
| 2025-03-31 | 47.03 | $49.73 | 0.95 |
| 2024-12-31 | 31.69 | $36.63 | 0.87 |
| 2024-09-30 | 21.70 | $15.29 | 1.42 |
| 2024-06-30 | 5.95 | $16.45 | 0.36 |
| 2024-03-31 | 14.39 | $16.09 | 0.89 |
| 2023-12-31 | 27.00 | $17.54 | 1.54 |
| 2023-09-30 | 30.38 | $23.45 | 1.30 |
| 2023-06-30 | 63.24 | $24.56 | 2.58 |
| 2023-03-31 | 151.50 | $25.19 | 6.01 |
| 2022-12-31 | 285.00 | $27.74 | 10.27 |
| 2022-09-30 | 225.00 | $30.58 | 7.36 |
| 2022-06-30 | 483.75 | $130.86 | 3.70 |
| 2022-03-31 | 615.00 | $226.19 | 2.72 |
| 2021-12-31 | 618.00 | $48.45 | 12.75 |
| 2021-09-30 | 674.99 | $243.13 | 2.78 |
| 2021-06-30 | 435.00 | $244.47 | 1.78 |
| 2021-03-31 | 405.00 | $252.98 | 1.60 |
| 2020-12-31 | 202.50 | $-32.18 | -6.29 |
| 2020-09-30 | 240.00 | $152.60 | 1.57 |
| 2020-06-30 | 240.00 | $178.01 | 1.35 |
| 2020-03-31 | 211.50 | $51.28 | 4.12 |
| 2019-12-31 | 300.00 | $59.93 | 5.01 |
| 2019-09-30 | 225.00 | $123.48 | 1.82 |
| 2019-06-30 | 300.00 | $195.57 | 1.53 |
| 2019-03-31 | 195.00 | $260.86 | 0.75 |
| 2018-12-31 | 375.00 | $-288.92 | -1.30 |
| 2018-09-30 | 1065.00 | $765.45 | 1.39 |
| 2018-06-30 | 1725.00 | $0.01 | 125912.41 |
| 2018-03-31 | 5205.00 | $0.02 | 299137.93 |
| 2017-12-31 | 3750.00 | $0.02 | 183823.53 |
| 2017-09-30 | 24750.00 | $0.05 | 521052.63 |
| 2017-06-30 | 7500.00 | 0.00 | |
| 2017-03-31 | 6750.00 | 0.00 | |
| 2016-12-31 | 5250.00 | $-0.15 | -35472.97 |
| 2016-09-30 | 6750.00 | 0.00 | |
| 2016-03-31 | 3000.00 | 0.00 | |
| 2015-12-31 | 2250.00 | 0.00 | |
| 2015-09-30 | 7500.00 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.670B | $0.480B |
| Nutex Health Inc. is a physician-led, technology-enabled healthcare services company. The Company's operating divisions include Hospital division and Population Health Management division. Hospital division implements and operates different health care models, including micro hospitals, specialty hospitals and hospital outpatient departments. Population Health Management division owns and operates provider networks such as Independent Physician Associations. Nutex Health Inc., formerly known as Clinigence Holdings Inc., is based in HOUSTON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.850B | 26.98 |
| Elevance Health (ELV) | United States | $84.468B | 10.90 |
| CVS Health (CVS) | United States | $83.959B | 10.44 |
| Cencora (COR) | United States | $56.658B | 19.71 |
| DiDi Global (DIDIY) | China | $22.826B | 24.25 |
| Natera (NTRA) | United States | $22.415B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.653B | 17.56 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.432B | 0.00 |
| Solventum (SOLV) | United States | $12.967B | 13.73 |
| CochLear (CHEOY) | Australia | $12.826B | 0.00 |
| ICON (ICLR) | Ireland | $11.783B | 10.95 |
| Revvity (RVTY) | United States | $11.516B | 19.82 |
| Viatris (VTRS) | United States | $10.434B | 3.58 |
| Avantor (AVTR) | United States | $9.254B | 13.45 |
| HealthEquity (HQY) | United States | $8.991B | 39.38 |
| Medpace Holdings (MEDP) | United States | $8.943B | 23.75 |
| Sonic Healthcare (SKHHY) | Australia | $8.181B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.378B | 14.46 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.305B | 25.35 |
| BrightSpring Health Services (BTSG) | United States | $3.975B | 36.47 |
| Sotera Health (SHC) | United States | $3.162B | 17.97 |
| Surgery Partners (SGRY) | United States | $2.782B | 36.18 |
| Alignment Healthcare (ALHC) | United States | $2.710B | 0.00 |
| Concentras Parent (CON) | United States | $2.631B | 15.21 |
| Organon (OGN) | United States | $2.600B | 2.76 |
| GeneDx Holdings (WGS) | United States | $2.537B | 97.72 |
| PACS (PACS) | United States | $1.951B | 0.00 |
| Ardent Health (ARDT) | United States | $1.877B | 8.00 |
| Premier (PINC) | United States | $1.799B | 13.66 |
| Progyny (PGNY) | United States | $1.792B | 39.45 |
| GoodRx Holdings (GDRX) | United States | $1.754B | 35.07 |
| Teladoc Health (TDOC) | United States | $1.328B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.171B | 8.91 |
| Establishment Labs Holdings (ESTA) | $1.084B | 0.00 | |
| CareDx (CDNA) | United States | $1.064B | 16.62 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.999B | 0.00 |
| Agilon Health (AGL) | United States | $0.902B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.806B | 7.54 |
| LifeMD (LFMD) | United States | $0.584B | 0.00 |
| Embecta (EMBC) | United States | $0.580B | 3.91 |
| InnovAge Holding (INNV) | United States | $0.516B | 0.00 |
| Enhabit (EHAB) | United States | $0.476B | 39.17 |
| Auna S.A (AUNA) | Luxembourg | $0.464B | 10.45 |
| Sonida Senior Living (SNDA) | United States | $0.455B | 0.00 |
| Omada Health (OMDA) | $0.452B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.442B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.301B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.258B | 0.00 |
| Beauty Health (SKIN) | United States | $0.242B | 0.00 |
| Oncology Institute (TOI) | United States | $0.192B | 0.00 |
| So-Young (SY) | China | $0.189B | 0.00 |
| DocGo (DCGO) | United States | $0.165B | 27.00 |
| Pheton Holdings (PTHL) | China | $0.113B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.095B | 0.00 |
| KindlyMD (NAKA) | United States | $0.085B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.075B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| ModivCare (MODV) | United States | $0.049B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |